FDA
approval
· 2017-03-28
FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Cipla USA Inc.)
Summary
FDA approved Cipla USA Inc.'s abacavir and lamivudine as a generic fixed-dose combination tablet for the treatment of HIV-1 infection in combination antiretrovi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)